NEW YORK TIMES CO-A (NYT) Fundamental Analysis & Valuation

NYSE:NYTUS6501111073

Current stock price

82.69 USD
+1.72 (+2.12%)
At close:
82.69 USD
0 (0%)
Pre-Market:

This NYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. NYT Profitability Analysis

1.1 Basic Checks

  • In the past year NYT was profitable.
  • NYT had a positive operating cash flow in the past year.
  • NYT had positive earnings in each of the past 5 years.
  • NYT had a positive operating cash flow in each of the past 5 years.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • With an excellent Return On Assets value of 11.48%, NYT belongs to the best of the industry, outperforming 96.74% of the companies in the same industry.
  • With an excellent Return On Equity value of 16.85%, NYT belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
  • NYT has a Return On Invested Capital of 15.25%. This is amongst the best in the industry. NYT outperforms 97.83% of its industry peers.
  • NYT had an Average Return On Invested Capital over the past 3 years of 13.02%. This is significantly above the industry average of 6.70%.
  • The last Return On Invested Capital (15.25%) for NYT is above the 3 year average (13.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.48%
ROE 16.85%
ROIC 15.25%
ROA(3y)10.13%
ROA(5y)9.16%
ROE(3y)15.09%
ROE(5y)14.09%
ROIC(3y)13.02%
ROIC(5y)11.96%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 12.18%, NYT belongs to the top of the industry, outperforming 92.39% of the companies in the same industry.
  • NYT's Profit Margin has improved in the last couple of years.
  • NYT has a Operating Margin of 16.47%. This is amongst the best in the industry. NYT outperforms 88.04% of its industry peers.
  • NYT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of NYT (50.81%) is better than 60.87% of its industry peers.
  • NYT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.47%
PM (TTM) 12.18%
GM 50.81%
OM growth 3Y12.73%
OM growth 5Y9.92%
PM growth 3Y17.36%
PM growth 5Y16.76%
GM growth 3Y2.18%
GM growth 5Y1.93%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. NYT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NYT is creating some value.
  • NYT has less shares outstanding than it did 1 year ago.
  • NYT has less shares outstanding than it did 5 years ago.
  • NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • NYT has an Altman-Z score of 11.20. This indicates that NYT is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.20, NYT belongs to the best of the industry, outperforming 96.74% of the companies in the same industry.
  • NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.2
ROIC/WACC1.69
WACC9.03%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • NYT has a Current Ratio of 1.54. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
  • NYT's Current ratio of 1.54 is fine compared to the rest of the industry. NYT outperforms 60.87% of its industry peers.
  • NYT has a Quick Ratio of 1.54. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of NYT (1.54) is better than 64.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.54
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

6

3. NYT Growth Analysis

3.1 Past

  • NYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.89%, which is quite impressive.
  • The Earnings Per Share has been growing by 20.55% on average over the past years. This is a very strong growth
  • The Revenue has grown by 9.24% in the past year. This is quite good.
  • NYT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.63% yearly.
EPS 1Y (TTM)22.89%
EPS 3Y26.16%
EPS 5Y20.55%
EPS Q2Q%11.25%
Revenue 1Y (TTM)9.24%
Revenue growth 3Y6.96%
Revenue growth 5Y9.63%
Sales Q2Q%10.42%

3.2 Future

  • Based on estimates for the next years, NYT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.80% on average per year.
  • The Revenue is expected to grow by 7.30% on average over the next years.
EPS Next Y12.06%
EPS Next 2Y12.44%
EPS Next 3Y8.8%
EPS Next 5YN/A
Revenue Next Year8.69%
Revenue Next 2Y7.51%
Revenue Next 3Y7.3%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

2

4. NYT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 33.48, the valuation of NYT can be described as expensive.
  • Based on the Price/Earnings ratio, NYT is valued a bit cheaper than the industry average as 67.39% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 25.54, NYT is valued a bit more expensive.
  • The Price/Forward Earnings ratio is 29.87, which means the current valuation is very expensive for NYT.
  • The rest of the industry has a similar Price/Forward Earnings ratio as NYT.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, NYT is valued a bit more expensive.
Industry RankSector Rank
PE 33.48
Fwd PE 29.87
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as NYT.
  • NYT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.32
EV/EBITDA 22.47
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • NYT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.78
PEG (5Y)1.63
EPS Next 2Y12.44%
EPS Next 3Y8.8%

6

5. NYT Dividend Analysis

5.1 Amount

  • NYT has a Yearly Dividend Yield of 1.13%.
  • Compared to an average industry Dividend Yield of 1.22, NYT pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, NYT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

  • The dividend of NYT is nicely growing with an annual growth rate of 24.09%!
  • NYT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NYT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)24.09%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 32.08% of the earnings are spent on dividend by NYT. This is a low number and sustainable payout ratio.
  • NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.08%
EPS Next 2Y12.44%
EPS Next 3Y8.8%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NYT Fundamentals: All Metrics, Ratios and Statistics

NEW YORK TIMES CO-A

NYSE:NYT (3/23/2026, 8:10:15 PM)

Premarket: 82.69 0 (0%)

82.69

+1.72 (+2.12%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners96.14%
Inst Owner Change-1.39%
Ins Owners0.59%
Ins Owner Change1.54%
Market Cap13.39B
Revenue(TTM)2.82B
Net Income(TTM)343.98M
Analysts76
Price Target70.9 (-14.26%)
Short Float %6.38%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend0.68
Dividend Growth(5Y)24.09%
DP32.08%
Div Incr Years6
Div Non Decr Years11
Ex-Date04-01
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.24%
Min EPS beat(2)0.98%
Max EPS beat(2)9.5%
EPS beat(4)4
Avg EPS beat(4)11.09%
Min EPS beat(4)0.98%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)15.56%
EPS beat(12)12
Avg EPS beat(12)21.54%
EPS beat(16)16
Avg EPS beat(16)23.99%
Revenue beat(2)2
Avg Revenue beat(2)0.44%
Min Revenue beat(2)0.39%
Max Revenue beat(2)0.49%
Revenue beat(4)3
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)1.24%
Revenue beat(8)3
Avg Revenue beat(8)-0.3%
Revenue beat(12)5
Avg Revenue beat(12)-0.44%
Revenue beat(16)6
Avg Revenue beat(16)-0.45%
PT rev (1m)1.88%
PT rev (3m)8.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.36%
EPS NY rev (1m)2.86%
EPS NY rev (3m)3.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.71%
Valuation
Industry RankSector Rank
PE 33.48
Fwd PE 29.87
P/S 4.74
P/FCF 24.32
P/OCF 22.91
P/B 6.56
P/tB 9.54
EV/EBITDA 22.47
EPS(TTM)2.47
EY2.99%
EPS(NY)2.77
Fwd EY3.35%
FCF(TTM)3.4
FCFY4.11%
OCF(TTM)3.61
OCFY4.37%
SpS17.45
BVpS12.61
TBVpS8.66
PEG (NY)2.78
PEG (5Y)1.63
Graham Number26.47
Profitability
Industry RankSector Rank
ROA 11.48%
ROE 16.85%
ROCE 19.96%
ROIC 15.25%
ROICexc 21.06%
ROICexgc 33.87%
OM 16.47%
PM (TTM) 12.18%
GM 50.81%
FCFM 19.49%
ROA(3y)10.13%
ROA(5y)9.16%
ROE(3y)15.09%
ROE(5y)14.09%
ROIC(3y)13.02%
ROIC(5y)11.96%
ROICexc(3y)17.41%
ROICexc(5y)16.06%
ROICexgc(3y)29%
ROICexgc(5y)25.57%
ROCE(3y)17.04%
ROCE(5y)15.65%
ROICexgc growth 3Y13.87%
ROICexgc growth 5Y20.41%
ROICexc growth 3Y18.82%
ROICexc growth 5Y13.04%
OM growth 3Y12.73%
OM growth 5Y9.92%
PM growth 3Y17.36%
PM growth 5Y16.76%
GM growth 3Y2.18%
GM growth 5Y1.93%
F-Score9
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 39.98%
Cap/Sales 1.2%
Interest Coverage 4190.35
Cash Conversion 106.24%
Profit Quality 160.04%
Current Ratio 1.54
Quick Ratio 1.54
Altman-Z 11.2
F-Score9
WACC9.03%
ROIC/WACC1.69
Cap/Depr(3y)33.83%
Cap/Depr(5y)41.29%
Cap/Sales(3y)1.09%
Cap/Sales(5y)1.31%
Profit Quality(3y)145.08%
Profit Quality(5y)121.45%
High Growth Momentum
Growth
EPS 1Y (TTM)22.89%
EPS 3Y26.16%
EPS 5Y20.55%
EPS Q2Q%11.25%
EPS Next Y12.06%
EPS Next 2Y12.44%
EPS Next 3Y8.8%
EPS Next 5YN/A
Revenue 1Y (TTM)9.24%
Revenue growth 3Y6.96%
Revenue growth 5Y9.63%
Sales Q2Q%10.42%
Revenue Next Year8.69%
Revenue Next 2Y7.51%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
EBIT growth 1Y24.88%
EBIT growth 3Y20.58%
EBIT growth 5Y20.51%
EBIT Next Year32.32%
EBIT Next 3Y17.62%
EBIT Next 5YN/A
FCF growth 1Y44.36%
FCF growth 3Y69.16%
FCF growth 5Y15.89%
OCF growth 1Y42.38%
OCF growth 3Y57.12%
OCF growth 5Y14.43%

NEW YORK TIMES CO-A / NYT Fundamental Analysis FAQ

What is the fundamental rating for NYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to NYT.


What is the valuation status of NEW YORK TIMES CO-A (NYT) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEW YORK TIMES CO-A (NYT). This can be considered as Overvalued.


What is the profitability of NYT stock?

NEW YORK TIMES CO-A (NYT) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for NYT stock?

The Price/Earnings (PE) ratio for NEW YORK TIMES CO-A (NYT) is 33.48 and the Price/Book (PB) ratio is 6.56.


Can you provide the expected EPS growth for NYT stock?

The Earnings per Share (EPS) of NEW YORK TIMES CO-A (NYT) is expected to grow by 12.06% in the next year.